BCDA
NasdaqCMBioCardia, Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 16 recent filings. 8 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Altman Peter Director, President and CEO | Buy (open market) | 5K | $0.78 | $3,900.00 | 2026-07-29 |
Altman Peter Director, President and CEO | Buy (open market) | 500 | $0.83 | $415.00 | 2026-07-17 |
Altman Peter Director, President and CEO | Buy (open market) | 2.8K | $0.88 | $2,464.00 | 2026-07-14 |
Altman Peter Director, President and CEO | Buy (open market) | 1.5K | $0.86 | $1,290.00 | 2026-07-15 |
Altman Peter Director, President and CEO | Buy (open market) | 5.5K | $0.97 | $5,335.00 | 2026-07-08 |
Altman Peter Director, President and CEO | Buy (open market) | 1K | $0.90 | $900.00 | 2026-07-09 |
Altman Peter Director, President and CEO | Buy (open market) | 1K | $0.94 | $940.00 | 2026-07-10 |
Altman Peter Director, President and CEO | Buy (open market) | 5.4K | $0.96 | $5,208.30 | 2026-07-08 |
STERTZER SIMON H Director | Grant / award | 8K | $0.00 | — | 2026-07-06 |
Slosman Marvin Director | Grant / award | 8K | $0.00 | — | 2026-07-06 |
Altman Peter Director, President and CEO | Tax withholding | 54.61K | $1.24 | $67,711.44 | 2026-07-02 |
Altman Peter Director, President and CEO | Grant / award | 57.69K | $0.00 | — | 2026-07-06 |
McClung David Chief Financial Officer | Tax withholding | 23.13K | $1.24 | $28,675.00 | 2026-07-02 |
McClung David Chief Financial Officer | Grant / award | 41.5K | $0.00 | — | 2026-07-06 |
GILLIS EDWARD M Senior Vice President, Devices | Tax withholding | 17.27K | $1.24 | $21,413.56 | 2026-07-02 |
GILLIS EDWARD M Senior Vice President, Devices | Grant / award | 29.44K | $0.00 | — | 2026-07-06 |
Source: SEC EDGAR Forms 4/4A (CIK 925741). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$BCDA
$BCDA CEO purchased 5,000 shares at $0.78 for a total of $3,900. Altman Peter now owns 373,885 shares. https://ceo-buys.com
$BCDA I’ve been purchasing shares at these firesale prices - THANK YOU market makers and shorts. Now, figuring out how to take the company private. Would you sell me your shares for $2.50?
$BCDA is this an 11 million dollar company due to funding issue, or because there’s no real path to commercial viability/profitability?
$BCDA
$BCDA reverse split occurs soon ?any inputs please?
$BCDA more insider buying today not much in amount but its something and they continue to buy im doing the same 18,000 + shares and counting
$BCDA QUEEZE HAPPENING, sell off cooling, we are at that moment were it starts to move up, or people give up. With recent news I believe bleed is over, time to start accumulating and rallying. Good luck everyone! See you at $25-$40
$BCDA CEO purchased 4,300 shares at $0.87 for a total of $3,754. Altman Peter now owns 368,385 shares. https://ceo-buys.com
$BCDA CEO Peter Altman brought another 4,300 shares today
$BCDA is a little squeeze coming?
$BCDA This may be an appropriate time to purchase additional shares and average down the overall cost basis, provided the investment thesis remains intact and the company’s fundamentals continue to be strong.
Latest news
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
New Strong Sell Stocks for July 14th
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
BioCardia Announces $4.4 Million Financing
Sector Update: Healthcare Stocks Higher Late Afternoon
Sector Update: Healthcare Stocks Gain Friday Afternoon
Top Midday Gainers
Why Did BCDA Stock Surge More Than 50% Today?
BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA)
BC-Most Active Stocks
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.